- Home
- Publications
- Publication Search
- Publication Details
Title
Role of HDL in Those with Diabetes
Authors
Keywords
HDL, apoA-I, Sphingosine-1-phosphate, LDL, Triglycerides, Phospholipids, HDL particles, HDL functionality, Reverse cholesterol transport, Atherosclerosis, Niacin, Fibrates, CETP inhibitor
Journal
Current Cardiology Reports
Volume 16, Issue 9, Pages -
Publisher
Springer Nature
Online
2014-06-20
DOI
10.1007/s11886-014-0512-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Paradoxical Association of Enhanced Cholesterol Efflux With Increased Incident Cardiovascular Risks
- (2013) Xin-Min Li et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Small, Dense High-Density Lipoprotein-3 Particles Are Enriched in Negatively Charged Phospholipids
- (2013) Laurent Camont et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Altered Activation of Endothelial Anti- and Proapoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery Disease
- (2013) Meliana Riwanto et al. CIRCULATION
- High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy
- (2013) Samia Mora et al. CIRCULATION
- High-Density Lipoprotein Particle Subclass Heterogeneity and Incident Coronary Heart Disease
- (2013) A. O. Akinkuolie et al.
- A novel approach to oral apoA-I mimetic therapy
- (2013) Arnab Chattopadhyay et al. JOURNAL OF LIPID RESEARCH
- The Addition of Niacin to Statin Therapy Improves High-Density Lipoprotein Cholesterol Levels But Not Metrics of Functionality
- (2013) Amit V. Khera et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
- (2013) Ramón Estruch et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functionality of postprandial larger HDL2 particles is enhanced following CETP inhibition therapy
- (2012) Natacha Bellanger et al. ATHEROSCLEROSIS
- Cholesterol Efflux and Atheroprotection
- (2012) Robert S. Rosenson et al. CIRCULATION
- Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial
- (2012) Thomas F. Lüscher et al. EUROPEAN HEART JOURNAL
- Changes in HDL cholesterol and cardiovascular outcomes after lipid modification therapy
- (2012) Kausik Ray et al. HEART
- High-Density Lipoprotein Cholesterol and Particle Concentrations, Carotid Atherosclerosis, and Coronary Events
- (2012) Rachel H. Mackey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
- (2012) Benjamin F Voight et al. LANCET
- The emerging role of HDL in glucose metabolism
- (2012) Brian G. Drew et al. Nature Reviews Endocrinology
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events
- (2011) R. S. Rosenson et al. CLINICAL CHEMISTRY
- The beneficial effects of HDL-C on atherosclerosis: rationale and clinical results
- (2011) Carlos G Santos-Gallego et al. Clinical Lipidology
- Experimental Models for the Investigation of High-Density Lipoprotein–Mediated Cholesterol Efflux
- (2011) Carlos G. Santos-Gallego et al. Current Atherosclerosis Reports
- Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes
- (2011) C. Morgantini et al. DIABETES
- Effect of Bariatric Surgery-Induced Weight Loss on SR-BI-, ABCG1-, and ABCA1-Mediated Cellular Cholesterol Efflux in Obese Women
- (2011) Judith Aron-Wisnewsky et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease
- (2011) Christian Besler et al. JOURNAL OF CLINICAL INVESTIGATION
- Reconstituted high-density lipoprotein infusion modulates fatty acid metabolism in patients with type 2 diabetes mellitus
- (2011) Brian G. Drew et al. JOURNAL OF LIPID RESEARCH
- Efficacy and Safety of a Novel Oral Inducer of Apolipoprotein A-I Synthesis in Statin-Treated Patients With Stable Coronary Artery Disease
- (2011) Stephen J. Nicholls et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
- (2011) Zahi A Fayad et al. LANCET
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
- (2011) Amit V. Khera et al. NEW ENGLAND JOURNAL OF MEDICINE
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Cholesterol Efflux Potential and Antiinflammatory Properties of High-Density Lipoprotein After Treatment With Niacin or Anacetrapib
- (2010) Laurent Yvan-Charvet et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Evidence That Niacin Inhibits Acute Vascular Inflammation and Improves Endothelial Dysfunction Independent of Changes in Plasma Lipids
- (2010) Ben J. Wu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Genetic Variation at the Phospholipid Transfer Protein Locus Affects Its Activity and High-Density Lipoprotein Size and Is a Novel Marker of Cardiovascular Disease Susceptibility
- (2010) Menno Vergeer et al. CIRCULATION
- Carriers of Loss-of-Function Mutations in ABCA1 Display Pancreatic -Cell Dysfunction
- (2010) M. Vergeer et al. DIABETES CARE
- RVX-208
- (2010) Dana Bailey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Alcohol Consumption and Mortality in Patients With Cardiovascular Disease
- (2010) Simona Costanzo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome
- (2010) Ron Waksman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial
- (2010) Paul M Ridker et al. LANCET
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
- (2010) Min Jun et al. LANCET
- Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease
- (2010) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- HDL3-Mediated Inactivation of LDL-Associated Phospholipid Hydroperoxides Is Determined by the Redox Status of Apolipoprotein A-I and HDL Particle Surface Lipid Rigidity
- (2009) Amal Zerrad-Saadi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Proteomic Analysis of Defined HDL Subpopulations Reveals Particle-Specific Protein Clusters
- (2009) W. Sean Davidson et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus
- (2009) Brian G. Drew et al. CIRCULATION
- Endothelial-Vasoprotective Effects of High-Density Lipoprotein Are Impaired in Patients With Type 2 Diabetes Mellitus but Are Improved After Extended-Release Niacin Therapy
- (2009) Sajoscha A. Sorrentino et al. CIRCULATION
- Effects of Rosuvastatin and Atorvastatin on LDL and HDL Particle Concentrations in Patients With Metabolic Syndrome: A randomized, double-blind, controlled study
- (2009) R. S. Rosenson et al. DIABETES CARE
- High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention
- (2009) K. J.E. Sattler et al. EUROPEAN HEART JOURNAL
- Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
- (2009) M. J. Chapman et al. EUROPEAN HEART JOURNAL
- Heart Disease and Stroke Statistics—2009 Update
- (2008) et al. CIRCULATION
- The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients
- (2008) Jean-Charles Fruchart et al. Diabetes & Vascular Disease Research
- Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
- (2008) R. Scott et al. DIABETES CARE
- Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients
- (2008) LeAnne T. Bloedon et al. JOURNAL OF LIPID RESEARCH
- Clinical Significance of High-Density Lipoprotein Cholesterol in Patients With Low Low-Density Lipoprotein Cholesterol
- (2008) Emil M. deGoma et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rapid Change in Plaque Size, Composition, and Molecular Footprint After Recombinant Apolipoprotein A-IMilano (ETC-216) Administration
- (2008) Borja Ibanez et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity
- (2007) Juliana A. de Souza et al. ATHEROSCLEROSIS
- Apolipoprotein A-IMilano/POPC complex attenuates post-ischemic ventricular dysfunction in the isolated rabbit heart
- (2007) Marta Marchesi et al. ATHEROSCLEROSIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation